ArticleBiomimetics (Basel, Switzerland)2025
Liver Tumor Segmentation Based on Multi-Scale Deformable Feature Fusion and Global Context Awareness.
Article in Biomimetics (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Multi-Scale Residual Gated Attention U-Net for Liver Tumor Segmentation.Journal of imaging informatics in medicine · 2026Article
- An intelligent healthcare framework for hepatocellular carcinoma diagnosis based on aggregated learners from biomedical data utilising explainable artificial intelligence.Scientific reports · 2026Article
- Deep Learning-Based Liver Tumor Segmentation from Computed Tomography Scans with a Gradient-Enhanced Network.Diagnostics (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The highly heterogeneous and irregular morphology of liver tumors presents considerable challenges for automated segmentation. To better capture complex tumor structures, this study proposes a liver tumor segmentation framework based on multi-scale deformable feature fusion and global context modeling. The method incorporates three key innovations: (1) a Deformable Large Kernel Attention (D-LKA) mechanism in the encoder to enhance adaptability to irregular tumor features, combining a large receptive field with deformable sensitivity to precisely extract tumor boundaries; (2) a Context Extraction (CE) module in the bottleneck layer to strengthen global semantic modeling and compensate for limited capacity in capturing contextual dependencies; and (3) a Dual Cross Attention (DCA) mechanism to replace traditional skip connections, enabling deep cross-scale and cross-semantic feature fusion, thereby improving feature consistency and expressiveness during decoding. The proposed framework was trained and validated on a combined LiTS and MSD Task08 dataset and further evaluated on the independent 3D-IRCADb01 dataset. Experimental results show that it surpasses several state-of-the-art segmentation models in Intersection over Union (IoU) and other metrics, achieving superior segmentation accuracy and generalization performance. Feature visualizations at both encoding and decoding stages provide intuitive insights into the model's internal processing of tumor recognition and boundary delineation, enhancing interpretability and clinical reliability. Overall, this approach presents a novel and practical solution for robust liver tumor segmentation, demonstrating strong potential for clinical application and real-world deployment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.